Time to Consider Emerging Market Bonds?
During the first quarter of 2008, bond markets went haywire. With investors increasingly worried about defaults, the average high-yield corporate-bond fund lost 3.6%, according to Morningstar.
During the first quarter of 2008, bond markets went haywire. With investors increasingly worried about defaults, the average high-yield corporate-bond fund lost 3.6%, according to Morningstar.
High gasoline prices are infuriating motorists, but for investors in energy stocks, the rocketing cost of fuel has been a blessing. With profits growing, shares of oil companies have been climbing impressively.
Researchers have found that the absence or presence of microhematuria does not accurately predict whether a distal ureteral stone is still present or has passed, according to a report in the Journal of Endourology (2008;22:1233-1236).
The lower the testosterone level achieved in men undergoing androgen deprivation therapy (ADT) for advanced prostate cancer, the better their chances of survival, an Italian study found.
NEW ORLEANS—Microalbuminuria is a biomarker for vascular disease and warrants aggressive treatment, which may prevent progression to overt nephropathy and reduce the risk of cardiovascular events, said Debjani Mukherjee, MD, at the 23rd scientific meeting of the American Society of Hypertension.
WASHINGTON, D.C.—Diabetics with neuropathy use more health- care resources than diabetics without this complication. In addition, among patients with diabetic neuropathy, those with comorbid depression or anxiety incur higher health-care costs than patients without these psychological problems.
ORLANDO—Serum cholesterol levels may have a role in prostate biology, according to a study.
CKD increases the risk of hospital-acquired acute renal failure (ARF), a study shows. The greater the degree of underlying renal impairment, the greater the ARF risk.
Parenteral estrogen therapy with high-dose polyestradiol phosphate (PEP, Estradurin) has anticancer efficacy similar to that of combined androgen deprivation (CAD) in patients with metastatic prostate cancer, researchers report.
Supplementation eases inflammation, lowers cardiac risk, and improves glycemic controls.